文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一组家族性高胆固醇血症患者的脂蛋白(a)浓度与心血管疾病——脂质门诊经验

Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia-A Lipid Clinic Experience.

作者信息

Kurdziel J, Fedak A, Kawalec E, Miarka P, Micek A, Małecki M, Walus-Miarka M

机构信息

Department of Metabolic Diseases and Diabetology, University Hospital, Krakow, Poland.

Department of Radiology, Jagiellonian University Medical College, Krakow, Poland.

出版信息

Clin Cardiol. 2025 May;48(5):e70125. doi: 10.1002/clc.70125.


DOI:10.1002/clc.70125
PMID:40331566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056595/
Abstract

BACKGROUND: High Lp(a) concentrations are linked to an increased risk of cardiovascular disease (CVD). However, more evidence is needed to assess the association of Lp(a) with CVD in different vascular beds. HYPOTHESIS: The aim was to assess the prevalence of increased Lp(a) levels and the association between Lp(a) levels and CVD in hypercholesterolemic patients. METHODS: We examined 220 patients (110 women) with suspicion of FH. The mean (SD) age was 49.1 (15.02) years, LDL-C 3.49 (1.75) mmol/L, and the median (IR) Lp(a) concentration 0.15 (0.53) g/L. RESULTS: CVD was present in 24.5%, coronary artery disease (CAD) in 21.4% of the examined individuals. Patients with CVD and patients with CAD had higher Lp(a) levels than patients without these diseases (p = 0.0403 and p = 0.0063, respectively); however, after adjustment for age and sex, only the difference in Lp(a) concentrations between persons with and without CAD remained significant. In total, 42.3% of patients who underwent carotid ultrasound examination had carotid plaques. We did not observe differences in Lp(a) levels between patients with or without plaques or correlations between Lp(a) and carotid IMT. In total, 28.3% of patients had Lp(a) concentrations in the high (> 0.5 g/dL), and 9.9% in the moderate-risk category (0.3-0.5 g/L). We observed an association between Lp(a) risk categories and the presence of CVD (p = 0.003) and CAD (p = 0.0004) but not with the presence of carotid plaques. CONCLUSIONS: We found a high prevalence of increased Lp(a) levels in a group of hyperlipidemic persons and strong associations of Lp(a) risk categories with CAD but not with carotid atherosclerosis.

摘要

背景:高脂蛋白(a)[Lp(a)]浓度与心血管疾病(CVD)风险增加有关。然而,需要更多证据来评估Lp(a)与不同血管床中CVD的关联。 假设:目的是评估高胆固醇血症患者中Lp(a)水平升高的患病率以及Lp(a)水平与CVD之间的关联。 方法:我们检查了220例疑似家族性高胆固醇血症(FH)的患者(110名女性)。平均(标准差)年龄为49.1(15.02)岁,低密度脂蛋白胆固醇(LDL-C)为3.49(1.75)mmol/L,Lp(a)浓度中位数(四分位间距)为0.15(0.53)g/L。 结果:24.5%的受检者存在CVD,21.4%存在冠状动脉疾病(CAD)。患有CVD和CAD的患者的Lp(a)水平高于无这些疾病的患者(分别为p = 0.0403和p = 0.0063);然而,在对年龄和性别进行调整后,只有患CAD和未患CAD者之间的Lp(a)浓度差异仍然显著。总共42.3%接受颈动脉超声检查的患者有颈动脉斑块。我们未观察到有或无斑块患者之间Lp(a)水平的差异,也未观察到Lp(a)与颈动脉内膜中层厚度(IMT)之间的相关性。总共28.3%的患者Lp(a)浓度处于高水平(>0.5 g/dL),9.9%处于中度风险类别(0.3 - 0.5 g/L)。我们观察到Lp(a)风险类别与CVD的存在(p = 0.003)和CAD的存在(p = 0.0004)之间存在关联,但与颈动脉斑块的存在无关。 结论:我们发现一组高脂血症患者中Lp(a)水平升高的患病率很高,且Lp(a)风险类别与CAD密切相关,但与颈动脉粥样硬化无关。

相似文献

[1]
Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia-A Lipid Clinic Experience.

Clin Cardiol. 2025-5

[2]
Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.

Atherosclerosis. 2015-9

[3]
Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia.

J Clin Lab Anal. 2018-9

[4]
The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.

Atherosclerosis. 2018-7-26

[5]
[Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].

Clin Investig Arterioscler. 2014

[6]
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.

Can J Cardiol. 2021-11

[7]
Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

J Am Coll Cardiol. 2014-3-13

[8]
Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.

Clin Cardiol. 2018-3

[9]
Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.

Atherosclerosis. 2017-5

[10]
Clinical Impact of Lipoprotein (a) and Cumulative Low-Density Lipoprotein Cholesterol Exposure on Coronary Artery Disease in Patients with Heterozygous Familial Hypercholesterolemia.

J Atheroscler Thromb. 2025-1-1

本文引用的文献

[1]
Screening for Subclinical Atherosclerosis in Patients with Familial Hypercholesterolemia: Insights and Implications.

J Clin Med. 2025-1-20

[2]
Measurement of lipoprotein(a) levels in real-world clinical and laboratory settings: a single-center experience.

Pol Arch Intern Med. 2024-11-28

[3]
Lipoprotein(a) and its impact on cardiovascular disease - the Polish perspective: design and first results of the Zabrze-Lipoprotein(a) Registry.

Arch Med Sci. 2024-8-29

[4]
Prevalence of hyperlipoproteinemia(a) in individuals of European ancestry treated at outpatient cardiology clinics: results from a cross-sectional STAR-Lp(a) study.

Pol Arch Intern Med. 2024-11-28

[5]
Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic review.

J Stroke Cerebrovasc Dis. 2024-12

[6]
Peripheral artery disease risk factors: A focus on lipoprotein(a).

Arch Cardiovasc Dis. 2024-10

[7]
Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.

Eur J Prev Cardiol. 2025-1-27

[8]
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.

J Am Coll Cardiol. 2024-3-5

[9]
The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke.

Brain Behav. 2024-1

[10]
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.

J Clin Lipidol. 2024

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索